Literature DB >> 11318963

Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.

M Sakatsume1, M Kadomura, I Sakata, N Imai, D Kondo, Y Osawa, H Shimada, M Ueno, T Miida, S Nishi, M Arakawa, F Gejyo.   

Abstract

BACKGROUND: Hyperlipoproteinemia is occasionally associated with severe glomerular injury caused by abnormal accumulation of lipid in glomeruli, which occurs in conditions such as lipoprotein glomerulopathy (LPG). This study investigates the cases of two siblings with homozygous apolipoprotein (apo) E2 who show unique histologic features, massive proteinuria, and dysbetalipoproteinemia.
METHODS: Histologic studies were performed using renal biopsy specimens. Plasma lipoproteins were extensively characterized. The exons of the apo E genes were sequenced to avoid missing any mutations.
RESULTS: Histologically, the siblings' condition resembled LPG by light microscopy studies. Electron microscopy studies revealed large lipoid deposits in the paramesangium, subendothelium, and subepithelium of the glomeruli, which were different from LPG in terms of not forming the layered structure resembling a fingerprint even in large lipoprotein thrombi, and mesangial foam cells. Immunohistochemically, the lipoid deposits contained apo E and apo B. These patients did not have either diabetic nephropathy or other known forms of glomerulonephritis. The sequence of exons of the apo E genes revealed homozygosity for apo E2 in both cases.
CONCLUSION: The extensive lipoprotein deposition in glomeruli, which resembles LPG, can also occur in apo E2 homozygous individuals, but in a distinct fashion. Because the two cases were siblings, they may have other shared alleles, in addition to the apo E2 allele, that negatively affect processing of lipoproteins and lead to abnormal accumulation of lipoprotein deposits in glomeruli.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318963     DOI: 10.1046/j.1523-1755.2001.0590051911.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

1.  Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka and Homozygous Apolipoprotein E2/2 without Dyslipidemia, with Characteristic Electron-Dense Deposits.

Authors:  Akihiko Koshino; Chikako Takaeda; Takahiro Matsuno; Shinji Kitajima; Yasunori Iwata; Norihiko Sakai; Kiyotaka Nagahama; Yo Niida; Takao Saito; Hitoshi Yokoyama; Takashi Wada
Journal:  Case Rep Nephrol Dial       Date:  2022-06-10

2.  A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes.

Authors:  Tamayo Kato; Yasuyuki Ushiogi; Hitoshi Yokoyama; Shigeo Hara; Akira Matsunaga; Eri Muso; Takao Saito
Journal:  CEN Case Rep       Date:  2019-01-30

Review 3.  Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.

Authors:  Miho Karube; Kimimasa Nakabayashi; Yasunori Fujioka; Ken Yoshihara; Akira Yamada; Akira Matsunaga; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

4.  A Common APOE Polymorphism Is an Independent Risk Factor for Reduced Glomerular Filtration Rate in the Spanish RENASTUR Cohort.

Authors:  Eliecer Coto; Juan Gómez; Beatriz Tavira; Salvador Tranche; Francisco Ortega; María I Rodríguez; Emilio Sánchez; Rafael Marín; Ana I Corao; Jorge Arenas; Victoria Alvarez
Journal:  Cardiorenal Med       Date:  2013-05-16       Impact factor: 2.041

5.  Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.

Authors:  Maria Katsarou; Efstratios Stratikos; Angeliki Chroni
Journal:  J Lipid Res       Date:  2018-10-11       Impact factor: 5.922

Review 6.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

7.  A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka.

Authors:  Hisako Hirashima; Toshiyuki Komiya; Naoya Toriu; Shigeo Hara; Akira Matsunaga; Takao Saito; Eri Muso
Journal:  Clin Nephrol Case Stud       Date:  2018-11-30

8.  A review on the role of quinones in renal disorders.

Authors:  Jennifer Madeo; Adeel Zubair; Frieri Marianne
Journal:  Springerplus       Date:  2013-04-01

9.  Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature.

Authors:  Kunio Kawanishi; Anri Sawada; Ayami Ochi; Takahito Moriyama; Michihiro Mitobe; Toshio Mochizuki; Kazuho Honda; Hideaki Oda; Toshio Nishikawa; Kosaku Nitta
Journal:  Case Rep Nephrol Urol       Date:  2013-11-28

Review 10.  Apolipoprotein E gene variants on the risk of end stage renal disease.

Authors:  Cheng Xue; Wei Nie; Dan Tang; Lujiang Yi; Changlin Mei
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.